Document text
Principal Investigator: ROY A. JENSEN
Organization: UNIVERSITY OF KANSAS MEDICAL CENTER
Fiscal Year: 2024
Award: $2,808,765
Funding agency: National Cancer Institute
OVERALL: ABSTRACT
The University of Kansas Cancer Center (KUCC) is a matrix consortium cancer center that includes: The
University of Kansas Medical Center (KUMC), the University of Kansas in Lawrence (KU-L) and via consortium
agreement, the Stowers Institute for Medical Research (Stowers) and Children’s Mercy (CM) Kansas City. In
2020, 171 members of KUCC accounted for $9.7M of NCI funding and a total of $57M in overall cancer-related
funding, an increase of $8M since the last CCSG submission. Supported by an experienced, nationally
recognized leadership team, Roy A. Jensen, MD, has led KUCC on a strong upward trajectory that has been
catalyzed by over $467M philanthropic support since 2004. Over the last four years, substantial progress has
been made broadening partnerships with communities throughout the KUCC catchment area, recruiting highly
innovative physician-scientists, and expanding clinical research and early phase clinical trials. We have also
been advancing education for the next generation of scientists and healthcare providers and heightening the
influence of KUCC researchers in the national scientific community. KUCC has established five aims to ensure
KUCC leads in the fight against cancer:
1. Leverage unique regional assets to transform research discoveries from the laboratory and the clinic to
drive new anticancer therapeutic development.
2. Provide the optimal environment to focus the power of precision medicine, basic science inquiry, drug
discovery and development, and behavioral interventions to decrease cancer incidence, morbidity, and
mortality.
3. Lead and implement a comprehensive strategy to educate both the current and next generation of cancer
researchers and clinicians in cancer research, treatment, prevention, and control.
4. Partner with key stakeholders, community advocates and regional leaders to develop, promote, and foster
research-based cancer prevention, diagnosis, treatment, control, and survivorship strategies to enhance
our national impact, improve cancer outcomes and ensure health equity.
5. Advance team science by fostering innovative partnerships and collaborations.
To accomplish these aims KUCC has three research programs: 1) Cancer Biology, 2) Cancer Prevention and
Control, and 3) Drug Discovery, Delivery and Experimental Therapeutics. In addition, KUCC supports the
Clinical Trials Office, seven established shared resources – Biospecimen, Biostatistics and Informatics, Clinical
Pharmacology, Flow Cytometry, Lead Development and Optimization, Nutrition, and Transgenic and Gene-
Targeting – and one developing shared resource – Microscopy & Analytical Imaging.
Terms: <0-11 years old><Achievement><Achievement Attainment><Advocacy><Advocate><Agreement><American><Basic Research><Basic Science><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Therapy><Behavioral Treatment><Biometrics><Biometry><Biostatistics><Breast><CCSG><Cancer Biology><Cancer Burden><Cancer Center><Cancer Center Support Grant><Cancer Control><Cancer Control Science><Cancer Treatment><Cancers><Caring><Catchment Area><Center for Cancer Research><Child><Child Youth><Children (0-21)><Cities><Clinic><Clinical><Clinical Pharmacology><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communities><Comprehensive Cancer Center><Conditioning Therapy><Development><Diagnosis><Education><Education and Training><Educational aspects><Ensure><Environment><Experimental Therapies><FDA approved><Ferroprotoporphyrin><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Fostering><Funding><Gene Targeting><Goals><Grant><Health Care Providers><Health Personnel><Healthcare Providers><Healthcare worker><Heme><Image><Incidence><Informatics><Institution><International><Intervention><Intervention Strategies><Investigational New Drug Application><Investigational Therapies><Investigational Treatments><Investigators><Kansas><Knowledge><Laboratories><Lead><Leadership><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Medical Research><Medical center><Microscopy><Morbidity><Morbidity - disease rate><NCI Center for Cancer Research><NCI-Designated Cancer Center><National Cancer Burden><Oncology><Oncology Cancer><Outcome><Patients><Pb element><Pediatric Oncology><Persons><Physicians><Position><Positioning Attribute><Prevention><Protoheme><Publications><QOL><Quality of life><Research><Research Infrastructure><Research Personnel><Researchers><Resource Sharing><Science><Scientific Publication><Scientist><Sight><Survey Instrument><Surveys><Technology><Therapeutic><Therapeutic Agents><Training><Training and Education><Transgenic Organisms><Underserved Population><Universities><Vision><anti-cancer research><anti-cancer therapeutic><anti-cancer therapy><behavior intervention><behavioral intervention><cancer prevention><cancer progenitor><cancer progenitor cells><cancer research><cancer stem cell><cancer therapy><cancer-directed therapy><clinical care><developmental><differentiation factors><drug development><drug discovery><early clinical trial><early phase clinical trial><early phase trial><experience><experimental therapeutic agents><experimental therapeutics><ferroheme><fighting><flow cytophotometry><health care personnel><health care worker><health equity><health provider><health workforce><healthcare personnel><heavy metal Pb><heavy metal lead><imaging><improved><innovate><innovation><innovative><interdisciplinary collaboration><interventional strategy><investigator-initiated trial><kids><malignancy><malignant progenitor><malignant stem cell><medical personnel><member><morphogenic factors><morphogens><mortality><multidisciplinary><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutics><new therapy><new therapy approaches><new treatment approach><new treatment strategy><next generation><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutics><novel therapy><novel therapy approach><nutrition><outreach><population health><precision medicine><precision-based medicine><progenitor biology><progenitor cell biology><programs><recruit><rural locality><rural place><rural setting><stem and progenitor biology><stem cell biology><survivorship><therapeutic agent development><therapeutic development><tobacco control><transdisciplinary collaboration><transgenic><treatment provider><under served group><under served individual><under served people><under served population><underserved group><underserved individual><underserved people><urban environment><urban setting><visual function><youngster>